Zevra Therapeutics, Inc. entered into a Contingent Value Rights Agreement with Computershare, Inc. and its affiliate, granting holders of contingent value rights cash payments upon achievement of certain milestones; Zevra completed the acquisition of Acer Therapeutics Inc. through a merger; Zevra entered into a Securities Purchase Agreement for a registered direct offering of shares and warrants; Press release issued announcing completion of the merger and pricing of the offering.